Eli Lilly insulin, customers will receive cash payments from a $13.5 million common fund
In a world of ever-rising healthcare costs, some uplifting news recently emerged. A long-standing lawsuit against a major insulin manufacturer, Eli Lilly & Co., has finally seen a significant breakthrough. The six-year journey of this complex litigation has led to a proposed class settlement that could bring substantial relief to